Progressive Grey Matter Alterations in Bipolar Disorder Across the Life Span - A Systematic Review
Overview
Affiliations
Objectives: To elucidate the relationship between the course of bipolar disorder (BD) and structural brain changes across the life span, we conducted a systematic review of longitudinal imaging studies in adolescent and adult BD patients.
Methods: Eleven studies with 329 BD patients and 277 controls met our PICOS criteria (participants, intervention, comparison, outcome and study design): BD diagnosis based on DSM criteria, natural course of disease, comparison of grey matter changes in BD individuals over ≥1-year interval between scans.
Results: The selected studies yielded heterogeneous findings, partly due to varying patient characteristics, data acquisition and statistical models. Mood episodes were associated with greater grey matter loss in frontal brain regions over time. Brain volume decreased or remained stable in adolescent patients, whereas it increased in healthy adolescents. Adult BD patients showed increased cortical thinning and brain structural decline. In particular, disease onset in adolescence was associated with amygdala volume reduction, which was not reported in adult BD.
Conclusions: The evidence collected suggests that the progression of BD impairs adolescent brain development and accelerates structural brain decline across the lifespan. Age-specific changes in amygdala volume in adolescent BD suggest that reduced amygdala volume is a correlate of early onset BD. Clarifying the role of BD in brain development across the lifespan promises a deeper understanding of the progression of BD patients through different developmental episodes.
[Long-term courses of bipolar disorders].
Czempiel T, Mikolas P, Bauer M, Vogel S, Ritter P Nervenarzt. 2024; 96(1):15-22.
PMID: 39709326 PMC: 11772376. DOI: 10.1007/s00115-024-01791-6.
Bellaagh Johansson T, Klahn A, Goteson A, Abe C, Sellgren C, Landen M Neuropsychobiology. 2024; 84(1):38-47.
PMID: 39626639 PMC: 11797920. DOI: 10.1159/000542888.
Gao W, Chen Y, Cui D, Zhu C, Jiao Q, Su L BMC Psychiatry. 2024; 24(1):762.
PMID: 39487398 PMC: 11531125. DOI: 10.1186/s12888-024-06208-x.
Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus.
Vieta E, Tohen M, McIntosh D, Kessing L, Sajatovic M, McIntyre R Bipolar Disord. 2024; 27(1):7-16.
PMID: 39438154 PMC: 11848019. DOI: 10.1111/bdi.13498.
Huang Y, Zhang J, He K, Mo X, Yu R, Min J Diagnostics (Basel). 2024; 14(4).
PMID: 38396428 PMC: 10888009. DOI: 10.3390/diagnostics14040389.